Biomarkers for RBM39 degradation in acute myeloid leukemia
David Hsiehchen1, Maria Goralski1, Jiwoong Kim2
1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Leukemia
|February 12, 2020
Abstract
No abstract available in PubMed .


